Alexza Pharmaceuticals Inc (ALXA)

0.94
0.01 1.63
Prev Close 0.92
Open 0.92
Day Low/High 0.91 / 0.95
52 Wk Low/High 0.22 / 1.60
Volume 305.73K
Avg Volume 144.20K
Exchange
Shares Outstanding 21.75M
Market Cap 20.01M
EPS -1.10
Div & Yield N.A. (N.A)

Latest News

ALEXZA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Ferrer Pharma, Inc. May Be Unfair To Shareholders

ALEXZA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Ferrer Pharma, Inc. May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Alexza...

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Alexza Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Alexza Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Alexza...

Alexza Pharmaceuticals Announces Interim Results From Its Phase 2a Study Of AZ-002 (Staccato® Alprazolam) In Epilepsy Patients

Alexza Pharmaceuticals Announces Interim Results From Its Phase 2a Study Of AZ-002 (Staccato® Alprazolam) In Epilepsy Patients

Interim Analysis Shows That AZ-002 Produces Dose-Related Decreases in Mean Standardized Photosensitivity Range

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Alexza Amends ADASUVE® Commercial Partnership Agreements

Alexza Amends ADASUVE® Commercial Partnership Agreements

Ferrer to Assume Additional Financial, Clinical, Regulatory and Commercial Responsibilities